Ingredient or product comparison
The FDA's Cosmetic vs Drug Classification System
The FDA does not approve cosmetic ingredients the way it approves drugs. It classifies products based on intended use, and that classification determines which regulatory pathway applies. A cosmetic is defined under 21 CFR 700.3 as a product 'intended to be ap
This source-based comparison does not add ratings or recommend a winner.
- The FDA does not approve cosmetic ingredients the way it approves drugs. It classifies products based on intended use, and that classification determines which regulatory pathway applies. A cosmetic is defined under 21 CFR 700.3 as a product 'intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, or altering appearance without affecting the body's structure or functions.' A drug, by contrast, is 'intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease' or 'intended to affect the structure or any function of the body.' The exact same molecule. Including GHK-Cu. Can be classified as either a cosmetic or a drug depending entirely on how it is marketed and what claims the manufacturer makes.
- GHK-Cu Cosmetic falls under cosmetic classification when it is sold for topical use in skincare formulations with claims related to appearance. Smoother skin, reduced visible signs of aging, improved skin texture. These are cosmetic claims. If a manufacturer markets the same peptide with claims that it 'stimulates collagen synthesis,' 'repairs damaged tissue,' or 'treats photoaging,' the FDA may classify that product as a drug, which would require pre-market approval through the New Drug Application (NDA) process. No GHK-Cu cosmetic product has received FDA approval as a drug, because the cosmetic pathway does not require it.
- The INCI database, maintained by the Personal Care Products Council, lists GHK-Cu as 'Copper Tripeptide-1'. A designation that allows its use in cosmetic formulations worldwide. INCI nomenclature is the international standard for ingredient labeling, and its inclusion in the INCI system signals that the ingredient has been reviewed for use in cosmetics, though not formally 'approved' in the pharmaceutical sense. The FDA recognizes INCI designations but does not grant approval based on INCI listing alone. Instead, the FDA holds manufacturers responsible for ensuring that any cosmetic ingredient they use is safe under intended conditions of use, as outlined in the Federal Food, Drug, and Cosmetic Act Section 601(a).
- Real Peptides supplies GHK CU Cosmetic 5MG as a research-grade peptide synthesized under controlled conditions with exact amino-acid sequencing. The peptide is intended for laboratory research applications, not for human cosmetic use, which places it outside the cosmetic-vs-drug regulatory distinction entirely. Research peptides are subject to different oversight. They are not marketed with cosmetic or therapeutic claims, and they are typically purchased by institutions conducting biological research on peptide mechanisms, not by consumers applying them topically. The GHK-Cu Cosmetic FDA approved status question most often applies to finished cosmetic products containing the peptide, not to the pure peptide itself when sold for research purposes.